Issue Date: December 3, 2007
Personalized Medicine Pow-wow
The 3rd Annual Burrill Personalized Medicine Meeting, hosted in San Francisco last month by the life sciences investment firm Burrill & Co., brought together biopharmaceutical researchers for a two-day discussion of the future of health care—a future that is already beginning to manifest itself in the way that drugs are discovered, developed, and delivered to patients.
Though somewhat nebulous, the term "personalized medicine" is generally understood to describe the practice of . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society